Coherus BioSciences lays off 20% of staff, while antimicrobial biotech makes deeper cuts
More layoffs have hit the biotech industry this week, with Coherus BioSciences saying it let go about 60 employees and an antimicrobial drug developer parting …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.